Numab raised €53M in a Series C round in Jan 2025. The company is based in Wadenswil, Switzerland. Investors in the round: Cormorant Asset Management, Forbion, HBM Healthcare Investments and 1 other. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
